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BACKGROUND

RESULTS

Procalcitonin (PCT) is used as a biomarker for the diagnosis of
serious bacterial infections (SBI).1,2 To date, studies have not
compared PCT to clinical judgment and it remains unclear
whether PCT adds to the physician’s clinical judgment when
diagnosing SBI.

Among the patients, 186 (46.5%) were diagnosed with an SBI
during their hospital stay.

PCT results were higher for patients who were diagnosed with an
SBI (median = 0.46) than for those who were not diagnosed with
an SBI (median = 0.12), U = 12365.5, z = -6.58, p < 0.001, r = 0.33.

OBJECTIVE
The current study evaluated the diagnostic usefulness of PCT in
comparison to blood culture results and the physician’s clinical
judgment in patients presenting to the Emergency Department
(ED) with signs of sepsis or other SBI.

METHODS
A prospective cohort study was conducted with 400 patients
suspected of having sepsis or an SBI who presented to the ED at
two community hospitals in Wisconsin from 2016 – 2018. PCT
was performed on all patients in addition to the standard of care
(SOC) for suspected SBI. PCT results were not available to the
physicians throughout the duration of the study.

Physicians completed a brief survey that asked if they thought
the patient was septic upon ordering SOC labs and again after
they reviewed the SOC lab results. Chart reviews were
conducted to collect study data and determine if patients were
diagnosed with an SBI during their hospital stay.

Multivariate logistic regression was used to examine factors
associated with an SBI diagnosis. All potential predictors that
were found to be significant during univariate analysis at the p ≤
0.10 significance level were included in the model.

The factors included in the model were PCT level3,4, sex, blood
culture result, ED volume/site, physician opinion of SBI pre-SOC
labs, physician opinion of SBI post-SOC labs, temperature >
100.4ºF or temperature < 96.8ºF, heart rate > 90, WBC > 12K or
WBC < 4K or WBC > 10% bands, glucose > 140 in absence of
diabetes, lactate > 2 mmol/L, C-reactive protein > 5 mg/dL, and
INR > 1.5 or PTT > 60 and not on anticoagulation.
A p-value of ≤ 0.05 was considered statistically significant.

Multivariate logistic regression analysis showed that, when
holding all other variables constant, high serum levels of PCT (≥
0.25 ng/mL) were an independently significant predictor for an
SBI diagnosis in patients with signs of infection (OR = 1.96, 95%
CI: 1.13-3.39, p = 0.016).

An ROC curve was used to evaluate the fit of the logistic
regression model. The area under the curve (AUC) was 0.857
with 95% confidence interval (.819, .895), p < 0.001. This
indicated the model was a good fit and classified the group
significantly better than by chance.5

In addition, patients suspected of having an SBI are 2.62 times
more likely to be diagnosed with an SBI when the blood culture
result is positive (OR = 2.62, 95% CI: 1.19-5.77, p = 0.017) and
7.13 times more likely to be diagnosed with an SBI when the
physician believes the patient is septic after reviewing the SOC
lab results (OR = 7.13, 95% CI: 3.64-13.97, p < 0.001).

CONCLUSIONS

There was no association between the physician’s clinical
judgment before reviewing the SOC lab results and SBI diagnosis
(OR = 1.74, 95% CI: 0.88-3.45, p = 0.111).

None of the other factors, including lactic acid, were found to be
significant predictors for an SBI diagnosis.

We found that PCT, blood culture results, and clinician judgment
after reviewing SOC lab results provide important diagnostic
value when diagnosing SBI.
Clinician judgment before reviewing SOC lab results was not
associated with an SBI diagnosis, thus SOC lab results do have
added value in aiding physician assessment of potential SBI.
This study offers a unique perspective as, to date, no other
studies have compared PCT results to clinical judgment.
Moreover, the methodology utilized in this study lends itself well
to additional examination of clinician judgment in the hospital
and clinic settings.
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